Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Clinical Research
  • Published:

Impact of diverticular disease on prostate cancer risk among hypertensive men

Subjects

Abstract

Introduction

Prostate cancer (PCa) is a heterogenous disease with multiple etiological factors playing a role in its development. Recently, chronic and systemic inflammatory conditions such as inflammatory bowel disease were identified as key risk factors influencing its development. The study aimed to evaluate the relationship between diverticular disease (DD) (local and acute inflammation) and PCa.

Methods

Hypertensive patients with DD and hypertensive controls were identified between 1995 and 2010 from the Statewide Planning and Research Cooperative System database. Cohorts were queried for PCa incidence through 2015. Univariable and multivariable logistic regression analyses were used for determining independent predictors of PCa diagnosis.

Results

A total of 51,353 patients with DD and 111,541 controls were identified. In all, 6.26% of DD developed PCa, and 3.71% of controls developed PCa (p < 0.01). DD was a significant risk factor for PCa (OR: 1.27 CI: 1.19–1.34, p < 0.01). On subgroup analysis, the patients diagnosed with DD <50 years old had an OR of 3.39 for PCa (CI: 2.52–4.56, p < 0.01), age 50–59 had an OR of 2.12 (CI: 1.86–2.15, p < 0.01), and age 60–69 had an OR of 1.20 (CI: 1.10–1.31, p < 0.01). Finally, age and race stratification showed that white patients <50 had an OR of 2.56 (CI: 1.75–3.76, p < 0.01), while black patients <50 had an OR of 3.98 (CI: 2.61–6.07, p < 0.01). The trend in differing odds between these populations was the same for age groups 50–59 and 60–69.

Conclusion

Our analysis shows that DD is associated with diagnosis of PCa in hypertensive men. Importantly, the earlier the diagnosis of DD, the higher the odds for development of PCa, particularly in black men.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Prostate cancer risk stratified by age of initial diagnosis of diverticular disease.
Fig. 2: Radiologic Images.

Similar content being viewed by others

References

  1. Cancer Stat Facts: Prostate Cancer. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. 2020. https://seer.cancer.gov/statfacts/html/prost.html

  2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. https://doi.org/10.3322/caac.21551

    Article  Google Scholar 

  3. Shoag J, Barbieri CE. Clinical variability and molecular heterogeneity in prostate cancer. Asian J Androl. 2016;18:543–8. https://doi.org/10.4103/1008-682X.178852

    Article  CAS  Google Scholar 

  4. Gann PH. Risk factors for prostate cancer. Rev Urol. 2002;4 Suppl 5:S3–S10.

    Google Scholar 

  5. Shtivelman E, Beer TM, Evans CP. Molecular pathways and targets in prostate cancer. Oncotarget. 2014;5:7217–59. https://doi.org/10.18632/oncotarget.2406

    Article  Google Scholar 

  6. Schoenborn JR, Nelson P, Fang M. Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification. Clin Cancer Res. 2013;19:4058–66. https://doi.org/10.1158/1078-0432.CCR-12-3606

    Article  CAS  Google Scholar 

  7. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–8. https://doi.org/10.1126/science.1117679

    Article  CAS  Google Scholar 

  8. Gonzalgo ML, Isaacs WB. Molecular pathways to prostate cancer. J Urol. 2003;170:2444–52. https://doi.org/10.1097/01.ju.0000085381.20139.b6

    Article  CAS  Google Scholar 

  9. Grasso CS, Wu YM, Robinson DR, Cao X, Dhanasekaran SM, Khan AP, et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature. 2012;487:239–43. https://doi.org/10.1038/nature11125

    Article  CAS  Google Scholar 

  10. Prostate Cancer Risk Factors. American Cancer Society. 2020. https://www.cancer.org/cancer/prostate-cancer/causes-risks-prevention/risk-factors.html

  11. Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study. Int J Cancer. 2007;121:1571–8. https://doi.org/10.1002/ijc.22788

    Article  CAS  Google Scholar 

  12. Burns JA, Weiner AB, Catalona WJ, Li EV, Schaeffer EM, Hanauer SB, et al. Inflammatory bowel disease and the risk of prostate cancer. Eur Urol. 2019;75:846–52. https://doi.org/10.1016/j.eururo.2018.11.039

    Article  Google Scholar 

  13. Ge YQ, Shi QQ, Yao WX, Cheng Y, Ma GX. The association between inflammatory bowel disease and prostate cancer risk: a meta-analysis. Prostate Cancer P D. 2020;23:53–58. https://doi.org/10.1038/s41391-019-0177-7

    Article  Google Scholar 

  14. Violi A, Cambie G, Miraglia C, Barchi A, Nouvenne A, Capasso M, et al. Epidemiology and risk factors for diverticular disease. Acta Biomed. 2018;89:107–12. https://doi.org/10.23750/abm.v89i9-S.7924

    Article  Google Scholar 

  15. Omidele OO, Davoudzadeh N, Palese M. Fellowship and subspecialization in urology: an analysis of robotic-assisted partial nephrectomy. Urology. 2019;130:36–42. https://doi.org/10.1016/j.urology.2019.03.028

    Article  Google Scholar 

  16. Omidele OO, Davoudzadeh N, Shah M, Tomer N, Palese M. Trends in utilization and perioperative outcomes in live donor nephrectomies: a multi-surgical discipline analysis. World J Urol. 2019;37:2225–30. https://doi.org/10.1007/s00345-018-2559-1

    Article  Google Scholar 

  17. Ravivarapu KT, Omidele O, Pfail J, Tomer N, Small AC, Palese MA. Robotic-assisted simple prostatectomy versus open simple prostatectomy: a New York statewide analysis of early adoption and outcomes between 2009 and 2017. J Robot Surg. 2020. https://doi.org/10.1007/s11701-020-01152-w

  18. Fryar, C. D., Ostchega, Y., Hales, C. M., Zhang, G. & Kruszon-Moran, D. Hypertension Prevalence and Control Among Adults: United States, 2015–2016. NCHS Data Brief, 1–8 (2017).

  19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373–83. https://doi.org/10.1016/0021-9681(87)90171-8

    Article  CAS  Google Scholar 

  20. Nettey OS, Walker AJ, Keeter MK, Singal A, Nugooru A, Martin IK, et al. Self-reported Black race predicts significant prostate cancer independent of clinical setting and clinical and socioeconomic risk factors. Urol Oncol. 2018;36:501 e501–501 e508. https://doi.org/10.1016/j.urolonc.2018.06.011

    Article  Google Scholar 

  21. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7. https://doi.org/10.1038/nature01322

    Article  CAS  Google Scholar 

  22. Korniluk A, Koper O, Kemona H, Dymicka-Piekarska V. From inflammation to cancer. Ir J Med Sci. 2017;186:57–62. https://doi.org/10.1007/s11845-016-1464-0

    Article  CAS  Google Scholar 

  23. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99. https://doi.org/10.1016/j.cell.2010.01.025

    Article  CAS  Google Scholar 

  24. Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41. https://doi.org/10.1016/j.immuni.2019.06.025

    Article  CAS  Google Scholar 

  25. Jiang J, Li J, Yunxia Z, Zhu H, Liu J, Pumill C. The role of prostatitis in prostate cancer: meta-analysis. PLoS One. 2013;8:e85179 https://doi.org/10.1371/journal.pone.0085179

    Article  CAS  Google Scholar 

  26. Sfanos KS, Yegnasubramanian S, Nelson WG, De Marzo AM. The inflammatory microenvironment and microbiome in prostate cancer development. Nat Rev Urol. 2018;15:11–24. https://doi.org/10.1038/nrurol.2017.167

    Article  Google Scholar 

  27. Barroso AO, Quigley EM. Diverticula and diverticulitis: time for a reappraisal. Gastroenterol Hepatol (N Y). 2015;11:680–8.

    Google Scholar 

  28. Feuerstein JD, Falchuk KR. Diverticulosis and diverticulitis. Mayo Clin Proc. 2016;91:1094–104. https://doi.org/10.1016/j.mayocp.2016.03.012

    Article  Google Scholar 

  29. Freeman HJ. Segmental colitis associated diverticulosis syndrome. World J Gastroenterol. 2016;22:8067–9. https://doi.org/10.3748/wjg.v22.i36.8067

    Article  Google Scholar 

  30. Schembri J, Bonello J, Christodoulou DK, Katsanos KH, Ellul P. Segmental colitis associated with diverticulosis: is it the coexistence of colonic diverticulosis and inflammatory bowel disease? Ann Gastroenterol. 2017;30:257–61. https://doi.org/10.20524/aog.2017.0126

    Article  Google Scholar 

  31. Carter H, Albertsen P, Barry M, et al. Early Detection of Prostate Cancer. AUA Guidelines. 2018. https://www.auanet.org/guidelines/guidelines/prostate-cancer-early-detection-guideline

  32. Rezapour M, Ali S, Stollman N. Diverticular disease: an update on pathogenesis and management. Gut Liver. 2018;12:125–32. https://doi.org/10.5009/gnl16552

    Article  CAS  Google Scholar 

  33. Carlson DS, Grivas P, Wei W, Dhillon PK, Abraksia S. The effectiveness of shared compared to informed decision making for prostate cancer screening in a high-risk African American population: a randomized control trial. Cancer Invest. 2021;39:124–32. https://doi.org/10.1080/07357907.2020.1855441.

  34. Merrill RM, Lyon JL. Explaining the difference in prostate cancer mortality rates between white and black men in the United States. Urology. 2000;55:730–5. https://doi.org/10.1016/s0090-4295(99)00564-6

    Article  CAS  Google Scholar 

  35. Dess RT, Hartman HE, Mahal BA, Soni PD, Jackson WC, Cooperberg MR, et al. Association of black race with prostate cancer-specific and other-cause mortality. JAMA Oncol. 2019;5:975–83. https://doi.org/10.1001/jamaoncol.2019.0826

    Article  Google Scholar 

  36. Dovey ZS, Nair SS, Chakravarty D, Tewari AK. Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies. Cancer Rep (Hoboken). 2021;e1341. https://doi.org/10.1002/cnr2.1340.

  37. Rayford W, Beksac AT, Alger J, Alshalalfa M, Ahmed M, Khan I, et al. Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences. Commun Biol. 2021;4:670 https://doi.org/10.1038/s42003-021-02140-y

    Article  CAS  Google Scholar 

  38. Yeo LX, Tseng TH, Chen WL, Kao TW, Wu LW, Fang WH, et al. Hypertension control and risk of colonic diverticulosis. Ther Adv Gastroenterol. 2019;12:1756284819855734 https://doi.org/10.1177/1756284819855734

    Article  Google Scholar 

  39. Gill D, Georgakis MK, Koskeridis F, Jiang L, Feng Q, Wei WQ, et al. Use of genetic variants related to antihypertensive drugs to inform on efficacy and side effects. Circulation. 2019;140:270–9. https://doi.org/10.1161/CIRCULATIONAHA.118.038814

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: NT, DC, and AKT; data collection, methodology, and formal analysis: NT and PR; writing (original draft preparation): NT and DC; writing (review and editing): NT, DC, PR, NM, IJ, ZD, MAP, and AKT; tables and figures: NT, IJ, and PR. All authors have provided critical feedback and have approved the manuscript.

Corresponding authors

Correspondence to Nir Tomer or Dimple Chakravarty.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tomer, N., Chakravarty, D., Ratnani, P. et al. Impact of diverticular disease on prostate cancer risk among hypertensive men. Prostate Cancer Prostatic Dis 25, 700–706 (2022). https://doi.org/10.1038/s41391-021-00454-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41391-021-00454-w

Search

Quick links